Related Blog Posts
Ramakrishnan on Indian science
7 hours ago ago from Calcutta Chronicles
The nanopolitan posts some excerpts from reports on Dr. Venkatraman Ramakrishnan's trip to India, his first after winning a Nobel Prize. I like the way he answers questions about whether he felt responsible to India and would return to help Indian research, he said essentially that the Indian public (including the Press and the Government) did not care about his views on this before he got the Nobel Prize, so he did not feel bound to ...
Related contentLife Science Companies and the Fda: How Change Control Software Transforms a Combatant Fist Fight Into a Picnic in the Park
23 hours ago ago from Money Blog
When you consider the relationship a life science company shares with the FDA it’s easy to visualize the love/hate kinship of a parent and child. It’s also simple to deduce who the parent might be. After all, the FDA Mama or Papa Bear has never been shy when it comes to playing by regulatory rules. The Goals of Life Science and the Goals of the FDA: Mutually Compatible or Mutually Exclusive? The goals of a life science company are ...
Related contentMLSC awards $25M in tax incentives to Mass. life sciences firms (Mass High Tech: The Journal of New England Technology)
21 hours ago ago from The New Bedford 10 - Top Ten Lists of the Best Restaurants, Businesses, Services, and Everything Else You Can Imagine in New Bedford, MA
The board of directors of the Massachusetts Life Sciences Center has awarded 28 life sciences companies a total of $25 million in tax incentives. The companies have agreed to create 918 jobs in the next year. See the original post: MLSC awards $25M in tax incentives to Mass. life sciences firms (Mass High Tech: The Journal of New England Technology)
Related contentProposed International Conference in Dec. 2010.
8 hours ago ago from Scientific Blogging - The world's best scientists. The internet's smartest readers. Science 2.0
Track your comments! [x] When you register, comments on your articles and replies to your comments appear here. Register Now ! Sign in to your account [x] Not a Scientific Blogging member yet? Register Now for a Free Scientificblogging.com Account Customize your profile with pictures, banner, a blogroll and more. Leave comments on articles, add other members to your friend lists, chat with people ...
Related contentDaily Pharma Watch
22 hours ago ago from GekkoWire
Alright Pharma Investors, we are a bit light on the news today, but heck that never stopped the daily pharma watch before! Arena Pharmaceuticals (ARNA): Arena announced some news yesterday, the company said Merck is going to terminate the collaboration agreement with them to develop MRK-1903, an atherosclerosis drug, due to the failure of it in mid-stage trials. The drug failed to meet the primary endpoint in a phase II study. I’ll be ...
Related contentRelated News
Nothing to see... move along.
Related Videos
Nothing to see... move along.
